West Family Investments’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,484	Closed	-$204K	–	300
2024 Q2	$204K	Hold	1,484	–	–	0.06%	236
2024 Q1	$205K	Buy	+1,484	New	+$205K	0.06%	243